Martin Hagedorn
2PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Feb 24, 2026
EZH2 is a key prognostic marker and therapeutic target in aggressive and proliferative hepatoblastoma.Fatma Zohra Khoubai, Alexia Calovoulos, Hélène Guillorit
|Mar 18, 2022
An EZH2 blocker sensitizes histone mutated diffuse midline glioma to cholesterol metabolism inhibitors through an off-target effect.Farah Rahal, Caroline Capdevielle, Benoit Rousseau
Pageof 1
